0001447362-24-000106.txt : 20240703
0001447362-24-000106.hdr.sgml : 20240703
20240703161541
ACCESSION NUMBER: 0001447362-24-000106
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oelschlager Kristen M
CENTRAL INDEX KEY: 0001856565
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38984
FILM NUMBER: 241100319
MAIL ADDRESS:
STREET 1: C/O CASTLE BIOSCIENCES
STREET 2: 505 S. FRIENDSWOOD DRIVE, SUITE 401
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC
CENTRAL INDEX KEY: 0001447362
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 770701774
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 S FRIENDSWOOD DRIVE
STREET 2: SUITE 401
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
BUSINESS PHONE: 866-788-9007
MAIL ADDRESS:
STREET 1: 505 S FRIENDSWOOD DRIVE
STREET 2: SUITE 401
CITY: FRIENDSWOOD
STATE: TX
ZIP: 77546
4
1
wk-form4_1720037734.xml
FORM 4
X0508
4
2024-07-01
0
0001447362
CASTLE BIOSCIENCES INC
CSTL
0001856565
Oelschlager Kristen M
C/O CASTLE BIOSCIENCES, INC.
505 S FRIENDSWOOD DRIVE, SUITE 401
FRIENDSWOOD
TX
77546
0
1
0
0
Chief Operating Officer
1
Common Stock
2024-07-01
4
S
0
2793
21.224
D
148618
D
The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by Kristen Oelschlager on March 15, 2024.
This transaction was executed in multiple trades at prices ranging from $20.890 to $21.705, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Includes 1,109 shares acquired on February 29, 2024, under the Issuer's employee stock purchase plan.
/s/ Frank Stokes, Attorney-in-fact
2024-07-03